Biologics is fastest growing segment fueling the growth of Inflammatory Bowel Disease Market
Inflammatory Bowel Disease Market The global Inflammatory Bowel Disease Market is estimated to be valued at US$ 2004.71 Mn or Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: Inflammatory Bowel Disease refers to a group of inflammatory conditions of the colon and small intestine. The major types of Inflammatory Bowel Disease are ulcerative colitis and Crohn's disease. Biologics play a crucial role in the treatment of inflammatory bowel disease by targeting specific components of the immune system and help manage symptoms and achieve remission with fewer side effects than other treatment options. Market key trends: One of the major trends in the inflammatory bowel disease market is increasing adoption of biologics. Biologics are monoclonal antibodies that target specific components of the immune system involved in inflammatory bowel disease. Th...